A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent or Persistent Endometrial Cancer

Administered By

Medicine, Medical Oncology

Awarded By

Alliance Foundation Trials, LLC

Contributors

Nixon, Andrew Benjamin Principal Investigator

Start/End

September 1, 2021 - August 31, 2022